Hedge Fund and Insider Trading News: David Einhorn, Alan Howard, Philippe Laffont, Nymox Pharmaceutical Co. (NYMX), ALJ Regional Holdings, Inc. (ALJJ), and More

Insider Buying: Nymox Pharmaceutical Co. (NYMX) Director Purchases 8,000 Shares of Stock (LedgerGazette.com)
Nymox Pharmaceutical Co. (NASDAQ:NYMX) Director James George Robinson acquired 8,000 shares of Nymox Pharmaceutical stock in a transaction on Monday, February 12th. The stock was purchased at an average cost of $3.27 per share, for a total transaction of $26,160.00. Following the purchase, the director now owns 3,107,850 shares in the company, valued at $10,162,669.50. The transaction was disclosed in a legal filing with the SEC.

Insider Selling: Seattle Genetics, Inc. (SGEN) Insider Sells 18,832 Shares of Stock (StockNewsTimes.com)
Seattle Genetics, Inc. (NASDAQ:SGEN) insider Clay B. Siegall sold 18,832 shares of the stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $49.75, for a total value of $936,892.00. The transaction was disclosed in a filing with the SEC.

AMN Healthcare Services, Inc. (AMN) Insider Ralph Henderson Sells 10,178 Shares (WeekHerald.com)
AMN Healthcare Services, Inc. (NYSE:AMN) insider Ralph Henderson sold 10,178 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $56.20, for a total value of $572,003.60. Following the sale, the insider now owns 37,574 shares in the company, valued at approximately $2,111,658.80. The sale was disclosed in a legal filing with the SEC.

Insider Buying: ALJ Regional Holdings, Inc. (ALJJ) Insider Buys 300,000 Shares of Stock (StockNewsTimes.com)
ALJ Regional Holdings, Inc. (NASDAQ:ALJJ) insider Jess M. Ravich acquired 300,000 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were acquired at an average price of $2.25 per share, for a total transaction of $675,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission.

Insider Selling: CBRE Group Inc (NYSE:CBG) Insider Sells 40,000 Shares of Stock (LedgerGazette.com)
CBRE Group Inc (NYSE:CBG) insider Robert E. Sulentic sold 40,000 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $42.56, for a total value of $1,702,400.00. Following the sale, the insider now owns 597,971 shares of the company’s stock, valued at $25,449,645.76. The transaction was disclosed in a legal filing with the SEC.